FLUIDDA nv: Clinical Trials

1 trial sponsored by FLUIDDA nv, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow FLUIDDA nv: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients
Functional Respiratory Imaging, Salmeterol xinafoate and Fluticasone propionate HFA pMDI, Seretide Evohaler - Asthma
Phase 3CompletedFLUIDDA nv162013-03-012013-09-19

Conditions studied

Asthma (1)

Interventions

Salmeterol Xinafoate (1)

Countries

Belgium (1)

Top investigators

Wilfried De Backer, MD, PhD (1)

Results publications

PMID 27227384